Fredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify. The microcap pharma stock has surged nearly 200% over the past year and 84% in 2026, reflecting strong investor interest and robust business momentum.